Top 5 gainers and losers in the midcap and smallcap segment during this week!

 Top 5 gainers and losers in the midcap and smallcap segment during this week!

Indian Market
by 5paisa Research Team Last Updated: 2022-11-04T17:23:06+05:30

List of top 5 gainers and losers in the midcap and smallcap segment for the week from October 28 to November 03, 2022.

The frontline index S&P BSE Sensex gained 1.01% or 877 points during the week and closed at 60836.41 on November 03,2022.

The positive rally was broad based during the week with the S&P BSE Mid Cap closing up by 1.02% at 25,646.28. The S&P BSE Small Cap also ended at 28,988.29 gaining 1.01%.

Let us have a look at the top 5 gainers and losers in the Midcap space for this week: 



Alembic Pharmaceuticals Ltd. 




Mazagon Dock Shipbuilders Ltd. 




Redington Ltd. 




Indigo Paints Ltd. 




Lemon Tree Hotels Ltd. 




The biggest gainer in the mid-cap segment for the week was Alembic Pharmaceuticals Ltd. Shares of this leading pharma manufacturer rose by 19.81% for the week from the levels of Rs 549.9 to Rs 658.85. The rally was on the back of receiving final approval from the USFDA for its anti-inflammatory Ketorolac Tromethamine Injection. The injection is used for short-term or less than five days of management of moderately severe acute pain in adults. Ketorolac Tromethamine Injection USP has an estimated market size of US$ 59 million for twelve months ending June 2022 according to IQVIA. This is the second injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.

The top 5 losers from the Midcap segment for this week are as follows:

LIC Housing Finance Ltd. 




Blue Dart Express Ltd. 




RHI Magnesita India Ltd. 




Deepak Fertilisers And Petrochemicals Corporation Ltd. 




PNB Housing Finance Ltd. 




The laggards of the midcap segment were led by LIC Housing Finance Ltd. The shares of the second largest housing finance player in India fell 12.15% from Rs 421 to Rs 369.85. The company reported Q2FY23 on November 2, wherein PAT plummeted 67% QoQ and came in at Rs 305crore. The subsidiary of LIC, the largest insurer posted NII at Rs 1163 crore which declined marginally from Rs 1173 crore. NIM also shrunk to 1.8% for the quarter for the housing finance company.

Let us move towards the top 5 gainers and losers in the smallcap segment:

The top 5 gainers in the smallcap segment for this week are as follows:  


The Karnataka Bank Ltd. 




Kabra Extrusiontechnik Ltd. 




Unichem Laboratories Ltd. 




Lancer Containers Lines Ltd. 




Kingfa Science & Technology (India) Ltd. 




 The top gainer in the Smallcap segment is Karnataka Bank Ltd. Shares of this private banker rose by 26.58% for the week from the levels of Rs 95.20 to Rs 120.505. The rally in the shares of this private banker was on the back of strong performance during the quarter that ended on September 30, 2022, wherein it reported the highest-ever quarterly Profit after Tax (PAT) of Rs 412 crore showing a 3x jump from Rs 126 crore on YoY basis. It also reported a strong NII of Rs 802.73 crore for the Q2 FY 2023 compared to Rs 637.10 crore on a YoY basis while registering a Net Interest Margin (NIM) of 3.78%. The shares of the company logged a fresh 52-week high at Rs 123.05 in the intraday trades on November 03.

The top 5 losers in the Smallcap segment for this week are as follows:

Mangalore Chemicals & Fertilizers Ltd. 




Intellect Design Arena Ltd. 




Vishnu Chemicals Ltd. 




Sportking India Ltd. 




WPIL Ltd. 




The losers of small-cap space were led by Mangalore Chemicals & Fertilizers Ltd. The shares of this company fell from Rs 117.4 to Rs 84 registering a loss of 28.45% in the stock price. The company reported Q2FY23 during the week, wherein net revenue degrew QoQ basis at Rs 289.78 crore from Rs 1027.18 crore However, the bottom line turned negative registering a loss of Rs 32.19 crore compared to a net profit of Rs 22.80 crore.

Start Investing in 5 mins*

Get Benefits worth 2100* | Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.

Open Free Demat Account

& get benefits worth 2100*

Resend OTP
Please Enter OTP
  • Have Promo code?
  • Use code ACT2100
Enter Promo code
Account belongs to

By proceeding, you agree to the T&C.

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number